Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 18/20 | 0.47 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.47 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6492318 | 0.95 | MCL1 (0.49) | MCL1BCL2L1PIN1 | |
| SCHEMBL6490634 | 0.91 | MCL1 (0.46) | MCL1BCL2L1 | |
| SCHEMBL6501595 | 0.85 | MCL1 (0.46) | MCL1BCL2L1 | |
| SCHEMBL6488041 | 0.83 | MCL1 (0.44) | MCL1BCL2L1 | |
| SCHEMBL6489668 | 0.83 | MCL1 (0.44) | MCL1BCL2L1 | |
| SCHEMBL6489813 | 0.82 | MCL1 (0.43) | MCL1PIN1 | |
| SCHEMBL6492356 | 0.82 | MCL1 (0.43) | MCL1BCL2L1 | |
| SCHEMBL6498711 | 0.82 | MCL1 (0.43) | MCL1BCL2L1 | |
| SCHEMBL6501594 | 0.82 | MCL1 (0.43) | MCL1BCL2L1 | |
| SCHEMBL6502699 | 0.81 | MCL1 (0.46) | MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | SLC5A1, SLC5A2, G6PD | MCL1 806/4885BCL2L1 1036/4885PIN1 2190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.